-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on GH Research, Raises Price Target to $39

Benzinga·01/06/2026 15:26:06
Listen to the news
Canaccord Genuity analyst Sumant Kulkarni maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $35 to $39.